Beta Drugs conducted the conference call for Q4 FY22. "Mgmt targets to grow at 30% CAGR for next 3-4 years" Here are the concall highlights 🧵

Beta Drugs conducted the conference call for Q4 FY22. "Mgmt targets to grow at 30% CAGR for next 3-4 years" Here are the concall highlights 🧵